SCHEMBL12732485

SCHEMBL12732485

B[C@@H](C)NC(=O)C(N)C(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 6/20 0.58
▸ FAP Q12884 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ DPP9 Q86TI2 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ SLC7A5 Q01650 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127016 0.82 DPP4 (0.62) DPP4FAPDPP8DPP9DPP7
SCHEMBL19334938 0.75 DPP4 (0.66) DPP4FAPDPP8DPP9DPP7
SCHEMBL11907188 0.72 DPP4 (0.52) DPP4FAPDPP8DPP9DPP7
SCHEMBL30853669 0.72 DPP4 (0.52) DPP4ALDH1A1MAPTPTGS1SLC7A5
SCHEMBL25650702 0.72 DPP4 (0.51) DPP4ALDH1A1MAPT
SCHEMBL31520397 0.72 DPP4 (0.51) DPP4FAPDPP8DPP9DPP7
SCHEMBL30811203 0.72 DPP4 (0.51) DPP4ALDH1A1MAPTPTGS1SLC7A5
SCHEMBL4083878 0.72 DPP4 (0.50) DPP4FAPDPP8DPP9DPP7
SCHEMBL20472978 0.72 DPP4 (0.50) DPP4FAPDPP8DPP9DPP7
SCHEMBL342534 0.72 DPP4 (0.50) DPP4FAPDPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170333461-A1 PEPTIDOMIMETIC INHIBITORS OF POST-PROLINE CLEAVING ENZYMES BACH BIOSCIENCES, LLC 2017-11-23 — — US disclosed
US-9757400-B2 Peptidomimetic inhibitors of post-proline cleaving enzymes TRUSTEES OF TUFTS COLLEGE (US) 2017-09-12 — — US disclosed
US-20160158260-A1 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes BACH BIOSCIENCES, LLC 2016-06-09 — — US disclosed
US-20110082108-A1 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes TRUSTEES OF TUFTS COLLEGE (US) 2011-04-07 — — US disclosed
US-7727964-B2 Peptidomimetic inhibitors of post-proline cleaving enzymes TRUSTEES OF TUFTS COLLEGE (US) 2010-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082108-A1 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes PREP, PEPD, DNPEP DPP4 4/4885FAP 19/4885DPP8 11/4885
US-20170333461-A1 PEPTIDOMIMETIC INHIBITORS OF POST-PROLINE CLEAVING ENZYMES PREP, PEPD, DNPEP DPP4 5/4885FAP 20/4885DPP8 11/4885
US-20160158260-A1 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes PREP, PEPD, DNPEP DPP4 5/4885FAP 20/4885DPP8 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback